$CODX people look at their coprimer technology, zika, malaria, TB. And the real value here is the potential SPEED of testing NEW diseases in future. It's not a ONE NIGHT STAND just for COVID-19. Unlike most other hit and run companies. I'm 95% sure its only a matter of time before a buyout. 🥳
  • 15
  • 12